Posts classified under: General

News + Announcements

GCAR Welcomes Financial Visionary Andrew Lo to Board of Directors

January 14, 2026  |  PRNEWSWIRE

Investigational Drug Tinostamustine to be Included in GBM AGILE Clinical Trial for Glioblastoma

September 17, 2025  |  BUSINESSWIRE

GCAR Announces Initiation of AZD1390 in GBM AGILE Trial

May 13, 2025  |  PRNewswire

U.S. Department of Defense Taps GCAR to be the Regulatory Lead for PTSD Trial

February 6, 2025  |  PRNewswire

GCAR Announces Evaluation of AZD1390 in GBM AGILE Trial

November 22, 2024  |  PRNewswire

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial

May 15, 2024  |  PRNewswire

PanCAN and GCAR Forge Alliance for Pancreatic Cancer Treatments

January 9, 2024  |  PRNewswire

GCAR Joins South Pole Trek 4 Cancer to Raise Funds for Research

November 2, 2023  |  BUSINESSWIRE

CTF & GCAR Announce Strategic Alliance for NF Platform Clinical Trial

October 5, 2023  |  PRNewswire

GCAR Launches GBM AGILE Trial for Brain Cancer Therapies

June 19, 2019  |  BUSINESSWIRE

GCAR Appoints Jeffrey Tarrant to Board of Directors

June 13, 2019  |  BUSINESSWIRE

FDA’s Woodcock Defends Accelerated Approvals and Talks of Culture Shift in Clinical Trials

June 5, 2019  |  BIOPHARMA DIVE

GCAR Names Meredith Buxton Chief Operating Officer

January 31, 2019  |  GLOBAL COALITION FOR ADAPTIVE RESEARCH

GCAR Names Gary Gordon as Interim Chief Executive Officer

November 8, 2018  |  PRWEB

4 Ways Cancer is Changing How We Test Medicines

October 18, 2018  |  POLITICO

GCAR Launches to Accelerate Cures for Rare and Deadly Diseases

April 16, 2018  |  BUSINESSWIRE

Could a New Business Model Make Clinical Drug Trials More Accessible to Patients?

March 8, 2018  |  HARVARD BUSINESS SCHOOL